Abstract:Highlights • Preparing pharmaceutical salts of tetrahydropalmatine-sulfamic acid (THP-SA). • Improving solubility of THP by forming THP-SA introducing sulfamic acid. • THP and SA form pharmaceutical salts with the superhelical structure. • The improved solubility of THP may be due to the supramolecular helical structure. In order to improve the solubility of tetrahydropalmatine (THP), based on the summary of the relationship between cocrystal/salt synthesis and conformation of the protoberberine type compounds, we hypothesized that by introducing sulfamic acid (SA) with the sulfonic acid group may form cocrystal with THP and improve the solubility of THP. An unreported pharmaceutical salt (C 21 H 26 NO 4 ·SO 3 NH 2 , THP-SA) with supramolecular helical structure of THP and SA was designed and synthesized, and its structural characterization and properties were investigated. Structural analysis showed that the pharmaceutical salt with supramolecular helical structure were formed by introducing SA with THP. In THP-SA pharmaceutical salts, the protons of hydroxyl groups on the introduced SA were transferred to the nitrogen atom of the THP via charge-assisted hydrogen bonding (+) CAHBs (N + -H···O − ) to form a stable crystal structure. Meanwhile, the S atom in the sulfamic acid forms an angle of 116.16° with the O atom, so that the two THP and the two SA are connected sequentially by the 116.16° angle formed between the S atom and the O atom under the action of C–H⋯O hydrogen bond to form the R 3 4 (17) supramolecular synthons. And THP and SA are alternately connected by C–H⋯O hydrogen bonds, forming a left-handed helical chain and a right-handed helical chain along the a-axis, and the left-handed helical chains and right-handed helical chains are connected by C–H⋯O hydrogen bonds formed between the O atoms in SA and the C atoms in THP to form a 3D supramolecular double helix structure. As expected, solubility studies showed that the solubility of THP-SA was significantly improved compared to that of THP. The reason may be that the introduction of SA makes THP and SA form a helical steric structure, and the intermolecular arrangement tightness is reduced, which is conducive to the entry of water molecules. And THP and SA depend on CAHBs to form pharmaceutical salts, which changes THP from neutral to ionized, resulting in increased solubility of THP. This work implies that THP can improve its physicochemical properties by introducing special coformers to form pharmaceutical salts with supramolecular helical structure, which provides a theoretical basis for the subsequent improvement of the physicochemical properties of the protoberberine type compounds. Graphical abstract Download : Download high-res image (329KB) Download : Download full-size image

Improving the sublimation stability of ligustrazine with gallic acid by forming pharmaceutical cocrystal based on the Etter's rules

Cocrystallization improves the tabletability of ligustrazine despite a reduction in plasticity

Improving hygroscopic stability of palmatine chloride by forming a pharmaceutical salt cocrystal of palmatine chloride-gallic acid with neutral molecule

Enhancing Stability and Formulation Capability of Fungicides by Cocrystallization Through a Novel Multistep Slurry Conversion Process

Improving Solubility and Avoiding Hygroscopicity of Tetrahydropalmatine by Forming a Pharmaceutical Salt Cocrystal via CAHBs

Exploring the Structural Landscape for a Thrombopoietin Receptor Agonist Avatrombopag Maleate: an Innovative Trihydrate Forms with Improved Solubility Found

Pharmaceutical Cocrystals of Ethenzamide: Molecular Structure Analysis Based on Vibrational Spectra and DFT Calculations

A New Strategy to Design Isostructural Salts: the Case of the Antitumor Drug Dimethylaminomicheliolide

Dual fungicides cocrystal of thiophanate-methyl and fludioxonil: Theoretical calculation and solubility studies

Improving the solubility of tetrahydropalmatine by introducing sulfonic acid by forming pharmaceutical salts of tetrahydropalmatine with supramolecular helical structure via CAHBs

Optimisation of Pharmaceutical Cocrystal Dissolution Performance through a Synergistic Precipitation Inhibition

A Drug–Drug Cocrystal Strategy to Regulate Stability and Solubility: A Case Study of Temozolomide/Caffeic Acid

Pharmaceutical properties of two ethenzamide-gentisic acid cocrystal polymorphs: Drug release profiles, spectroscopic studies and theoretical calculations

Structure Solution of ACV-GLU Cocrystal by Combined XRD Refinement, 1D Solid State NMR and DFT Calculations

Chemical stabilization strategy for cymoxanil: synthesis and characterization of cocrystals with small organic acids

Theoretical and experimental cocrystal screening of temozolomide with a series of phenolic acids, promising cocrystal coformers

Study on co-amorphous emerging solubilization behavior after gelation during dissolution: The importance of complexation and anti-crystallization

Bioavailability-Enhancing Cocrystals: Screening, In Vivo Predictive Dissolution, and Supersaturation Maintenance

The mechanism of binding with the α-glucosidase in vitro and the evaluation on hypoglycemic effect in vivo: Cocrystals involving synergism of gallic acid and conformer

Effect of Surfactants and Polymers on the Dissolution Behavior of Supersaturable Tecovirimat-4-Hydroxybenzoic Acid Cocrystals

Polymorph selection of pharmaceutical cocrystals via bench-top and continuous production techniques